Kishor Devalaraja-Narashimha

Kishor Devalaraja-Narashimha

Regeneron Pharmaceuticals Inc - Warsaw / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4417567
-
person_outline Kishor Devalaraja-Narashimha's MOST POPULAR ARTICLES
1-) Defining the activated fibroblast population in lung fibrosis using single-cell sequencingR Peyser, S MacDonnell, Y Gao, L Cheng, Y Kim, T Kaplan, Q Ruan, ...American journal of respiratory cell and molecular biology 61 (1), 74-85, 20191262019
2-) Cyclophilin D gene ablation protects mice from ischemic renal injuryK Devalaraja-Narashimha, AM Diener, BJ PadanilamAmerican Journal of Physiology-Renal Physiology 297 (3), F749-F759, 20091242009
3-) Poly (ADP-ribose) polymerase-1 gene ablation protects mice from ischemic renal injuryJ Zheng, K Devalaraja-Narashimha, K Singaravelu, BJ PadanilamAmerican Journal of Physiology-Renal Physiology 288 (2), F387-F398, 20051182005
4-) PARP-1 inhibits glycolysis in ischemic kidneysK Devalaraja-Narashimha, BJ PadanilamJournal of the American Society of Nephrology 20 (1), 95-103, 2009952009
5-) Urinary single-cell profiling captures the cellular diversity of the kidneyA Abedini, YO Zhu, S Chatterjee, G Halasz, K Devalaraja-Narashimha, ...Journal of the American Society of Nephrology 32 (3), 614-627, 2021792021